Email this article to a friend
The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
-
* Corresponding author: Frank Speleman franki.speleman@ugent.be
Genome Med 2009, 1:74 doi:10.1186/gm74